Drugs / rBV A/B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01701999 | Feb 2013 → Jun 2015 | botulism | California Department of Public Health | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rBV A/B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01701999 ↗ |
| Modality | Vaccine | “investigational recombinant botulinum vaccine for botulinum neurotoxin (BoNT) serotypes A and B (rBV A/B)” PMID 29475762 ↗ Feb 2018 |
| Route | Intramuscular | “A single 0.5 ml (mL), 40-microgram intramuscular injection of rBV A/B was administered to study participants.” PMID 29475762 ↗ Feb 2018 |